A TB program shows high completion of preventive therapy in migrants, suggesting 1HP regimen is effective.
In a U.S. health department TB program serving primarily non-U.S.-born clients, 78% of those evaluated for latent TB infection initiated TB preventive therapy, with 71% completing treatment. Completion was lower among newly arrived migrants. A novel one-month isoniazid-rifapentine regimen (1HP) was well tolerated, with similar completion rates to conventional regimens.
No takes yet. Share an insight, caveat, or question.
Starke et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: